Delivery Order SPE2DB22D1041-SPE2DB24FTZD0

Award Date 1/8/24
Potential Completion Date 1/9/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $15,055.71, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999. The IDC, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award, valued at $14,172.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $4,475.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,626.87 firm fixed-price delivery order is for the medication AMLOD-VALSA-HCTZ 10-160-12.5MG 30S, and has a completion date of November 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,897.80 firm fixed-price delivery order covers the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a medical product, with a completion date of December 26, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,772.55, is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. The award covers the procurement of pharmaceutical products, including AMLOD-VALSA-HCTZ 10-320-25 MG 30S. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medication. The $1,598.19 Firm Fixed Price contract has an ultimate completion date of October 18, 2024. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC, which runs through...
This federal contract award, valued at $8,345.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The specific award is for the delivery of 4565455921 - AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,654.18 firm fixed-price delivery order covers the supply of AMLOD-VALSA-HCTZ 10-320-25 MG medication in 30-count packages. The contract has a completion date of February 26, 2025 and was awarded on February 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,446.30 firm fixed-price delivery order is for AMLOD-VALSA-HCTZ 10-160-25 MG 30S, a cardiovascular medication. The contract has an ultimate completion date of March 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FTZD0
    Delivery Order

This federal contract award, valued at $16,200.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The current Delivery Order is for a specific product, AMLOD-VALSA-HCTZ 10-320-25 MG 30S, with a completion date of January 9, 2024. The contract is a Firm Fixed Price arrangement and was not designated with any set-aside requirements, indicating open competition.

Generated 5/13/25, 9:45 AM